Vancomycin

Back to search

Molecule Structure

Scientific Name

Vancomycin

Description of the Drug

Vancomycin is a glycopeptide antibiotic used to treat severe but susceptible bacterial infections such as MRSA (methicillin-resistant Staphylococcus aureus) infections.

Source: DrugBank Online – DrugBank.com. Retrieved 2023-02-07 from
http://www.drugbank.ca/drugs/DB00512

Brand Name(s)

Not Available

Company Owner(s)

Sagent Pharmaceuticals Inc, Watson Laboratories Inc, Fresenius Kabi Usa Llc, Samson Medical Technologies Llc, Orient Pharma Co Ltd, Lupin Ltd, Azurity Pharmaceuticals Inc, Ani Pharmaceuticals Inc, Teva Pharmaceuticals Usa, Sandoz Inc

Mechanism(s) Of Action

Target Name Target Type Action Type Target ChEMBL ID
Peptidoglycan MACROMOLECULE INHIBITOR CHEMBL3041361

Unichem Links

SureChEMBL SCHEMBL3177
PharmGKB PA451850
Human Metabolome Database HMDB0014653
WDI VANCOMYCI
DrugBank DB00512
PubChem: Thomson Pharma 14842128 14842127
PubChem 14969
LINCS LSM-45214
Nikkaji J34.275K
BindingDB 50335519
EPA CompTox Dashboard DTXSID0042664
DrugCentral 2807
Metabolights MTBLC28001
Guide to Pharmacology 10932
GSRS c0145b5f-0f77-4810-9917-f89115347e45
rxnorm VANCOMYCIN HYDROCHLORIDE VANCOMYCIN VANCOCIN
ChEBI 28001